A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE)
Platt, Heather L., Cardona, Jose F., Haranaka, Miwa, Schwartz, Howard I., Narejos Perez, Silvia, Dowell, Anthony, Chang, Chih-Jen, Dagan, Ron, Tamms, Gretchen M., Sterling, Tina, Morgan, Leslie, Shi, Yaru, Pedley, Alison, Musey, Luwy K., Buchwald, Ulrike K.
Published in Vaccine (03.01.2022)
Published in Vaccine (03.01.2022)
Get full text
Journal Article
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants
Greenberg, David, Hoover, Patricia A., Vesikari, Timo, Peltier, Christopher, Hurley, David C., McFetridge, Richard D., Dallas, Michael, Hartzel, Jonathan, Marchese, Rocio D., Coller, Beth-Ann G., Stek, Jon E., Abeygunawardana, Chitrananda, Winters, Michael A., MacNair, John E., Pujar, Narahari S., Musey, Luwy
Published in Vaccine (29.10.2018)
Published in Vaccine (29.10.2018)
Get full text
Journal Article
A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants
Platt, Heather L, Greenberg, David, Tapiero, Bruce, Clifford, Robert A, Klein, Nicola P, Hurley, David C, Shekar, Tulin, Li, Jianing, Hurtado, Kim, Su, Shu-Chih, Nolan, Katrina M, Acosta, Camilo J, McFetridge, Richard D, Bickham, Kara, Musey, Luwy K
Published in The Pediatric infectious disease journal (01.08.2020)
Published in The Pediatric infectious disease journal (01.08.2020)
Get more information
Journal Article
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults
Stacey, Helen L., Rosen, Jeffrey, Peterson, James T., Williams-Diaz, Angela, Gakhar, Vanita, Sterling, Tina M., Acosta, Camilo J., Nolan, Katrina M., Li, Jianing, Pedley, Alison, Benner, Patrice, Abeygunawardana, Chitrananda, Kosinski, Michael, Smith, William J., Pujar, Hari, Musey, Luwy K.
Published in Human vaccines & immunotherapeutics (04.03.2019)
Published in Human vaccines & immunotherapeutics (04.03.2019)
Get full text
Journal Article
Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence
Niederman, Michael S, Folaranmi, Temitope, Buchwald, Ulrike K, Musey, Luwy, Cripps, Allan W, Johnson, Kelly D
Published in Expert review of vaccines (04.03.2021)
Published in Expert review of vaccines (04.03.2021)
Get more information
Journal Article
Safety and Immunogenicity of V114, a 15-valent Pneumococcal Conjugate Vaccine, Compared with 13-valent Pneumococcal Conjugate Vaccine in Japanese Adults Aged ≥65 Years: Subgroup Analysis of a Randomized Phase III Trial (PNEU-AGE)
Kishino, Hiroyuki, Sawata, Miyuki, Igarashi, Rie, Shirakawa, Masayoshi, Pedley, Alison, Musey, Luwy, Platt, Heather Loryn, Buchwald, Ulrike Kirsten
Published in Japanese Journal of Infectious Diseases (30.11.2022)
Published in Japanese Journal of Infectious Diseases (30.11.2022)
Get full text
Journal Article
Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects
Adler, Stuart P, Lewis, Nicole, Conlon, Anthony, Christiansen, Mark P, Al-Ibrahim, Mohamed, Rupp, Richard, Fu, Tong-Ming, Bautista, Oliver, Tang, Huaping, Wang, Dai, Fisher, Alison, Culp, Timothy, Das, Rituparna, Beck, Karen, Tamms, Gretchen, Musey, Luwy
Published in The Journal of infectious diseases (02.07.2019)
Published in The Journal of infectious diseases (02.07.2019)
Get full text
Journal Article
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged ≥50 years: A randomized phase III trial (PNEU-PATH)
Song, Joon-Young, Chang, Chih-Jen, Andrews, Charles, Diez-Domingo, Javier, Oh, Myoung-don, Dagan, Ron, Hartzel, Jonathan, Pedley, Alison, Li, Jianing, Sterling, Tina, Tamms, Gretchen, Chiarappa, Joseph A., Lutkiewicz, Jeannine, Musey, Luwy, Tu, Yingmei, Buchwald, Ulrike K.
Published in Vaccine (15.10.2021)
Published in Vaccine (15.10.2021)
Get full text
Journal Article
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age
Ermlich, Susan J., Andrews, Charles P., Folkerth, Steven, Rupp, Richard, Greenberg, David, McFetridge, Richard D., Hartzel, Jonathan, Marchese, Rocio D., Stek, Jon E., Abeygunawardana, Chitrananda, Musey, Luwy K.
Published in Vaccine (29.10.2018)
Published in Vaccine (29.10.2018)
Get full text
Journal Article
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)
Severance, Randall, Schwartz, Howard, Dagan, Ron, Connor, Laurie, Li, Jianing, Pedley, Alison, Hartzel, Jonathan, Sterling, Tina M., Nolan, Katrina M., Tamms, Gretchen M., Musey, Luwy K., Buchwald, Ulrike K.
Published in Human vaccines & immunotherapeutics (31.12.2022)
Published in Human vaccines & immunotherapeutics (31.12.2022)
Get full text
Journal Article
Functional Evaluation and Genetic Evolution of Human T-Cell Responses After Vaccination With a Conditionally Replication-Defective Cytomegalovirus Vaccine
Cox, Kara S, Zhang, Lu, Freed, Daniel C, Tang, Aimin, Zhang, Shifang, Zhou, Yu, Wang, I-Ming, Rupp, Richard E, Adler, Stuart P, Musey, Luwy K, Wang, Dai, Vora, Kalpit A, Fu, Tong-Ming
Published in The Journal of infectious diseases (04.06.2021)
Published in The Journal of infectious diseases (04.06.2021)
Get full text
Journal Article
Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults
McFetridge, Richard, Meulen, Ajoke Sobanjo-ter, Folkerth, Steven D, Hoekstra, John A, Dallas, Michael, Hoover, Patricia A, Marchese, Rocio D, Zacholski, Donna M, Watson, Wendy J, Stek, Jon E, Hartzel, Jonathan S, Musey, Luwy K
Published in Vaccine (04.06.2015)
Published in Vaccine (04.06.2015)
Get full text
Journal Article
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
Peterson, James T., Stacey, Helen L., MacNair, John E., Li, Jianing, Hartzel, Jonathan S., Sterling, Tina M., Benner, Patrice, Tamms, Gretchen M., Musey, Luwy K.
Published in Human vaccines & immunotherapeutics (04.03.2019)
Published in Human vaccines & immunotherapeutics (04.03.2019)
Get full text
Journal Article
Safety, tolerability and immunogenicity of 15-valent pneumococcal conjugate vaccine in toddlers previously vaccinated with 7-valent pneumococcal conjugate vaccine
Sobanjo-ter Meulen, Ajoke, Vesikari, Timo, Malacaman, Edgardo A, Shapiro, Steven A, Dallas, Michael J, Hoover, Patricia A, McFetridge, Richard, Stek, Jon E, Marchese, Rocio D, Hartzel, Jonathan, Watson, Wendy J, Musey, Luwy K
Published in The Pediatric infectious disease journal (01.02.2015)
Published in The Pediatric infectious disease journal (01.02.2015)
Get more information
Journal Article
The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C
Shi, Yaru, Nolan, Katrina M, Burton, Robert L, Shekar, Tulin, Murphy, Rocio D, Banniettis, Natalie, Musey, Luwy, Buchwald, Ulrike K
Published in Human vaccines & immunotherapeutics (01.08.2023)
Published in Human vaccines & immunotherapeutics (01.08.2023)
Get full text
Journal Article
Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older
Buchwald, Ulrike K., Andrews, Charles P., Ervin, John, Peterson, James T., Tamms, Gretchen M., Krupa, David, Ajiboye, Patrick, Roalfe, Lucy, Krick, Andrea L., Sterling, Tina M., Wang, Meihua, Martin, Jason C., Stek, Jon E., Kohn, Melvin A., Folaranmi, Temitope, Abeygunawardana, Chitrananda, Hartzel, Jonathan, Musey, Luwy K.
Published in Human vaccines & immunotherapeutics (03.08.2021)
Published in Human vaccines & immunotherapeutics (03.08.2021)
Get full text
Journal Article
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors
Hammitt, Laura L., Quinn, Dean, Janczewska, Ewa, Pasquel, Francisco J., Tytus, Richard, Reddy, K. Rajender, Abarca, Katia, Khaertynova, Ilsiyar M., Dagan, Ron, Dawson, Rachel, McCauley, Jennifer, Shekar, Tulin, Fu, Wei, Pedley, Alison, Sterling, Tina, Tamms, Gretchen, Musey, Luwy, Buchwald, Ulrike K.
Published in Human vaccines & immunotherapeutics (31.12.2023)
Published in Human vaccines & immunotherapeutics (31.12.2023)
Get full text
Journal Article
Time interval of revaccination with 23-valent pneumococcal polysaccharide vaccine more than 5 years does not affect the immunogenicity and safety in the Japanese elderly
Kawakami, Kenji, Kishino, Hiroyuki, Kanazu, Shinichi, Takahashi, Kenichi, Iino, Tomoharu, Sawata, Miyuki, Musey, Luwy
Published in Human vaccines & immunotherapeutics (03.08.2018)
Published in Human vaccines & immunotherapeutics (03.08.2018)
Get full text
Journal Article
Tolerability of Two Sequential Electroporation Treatments Using MedPulser DNA Delivery System (DDS) in Healthy Adults
Wallace, Mark, Evans, Barbara, Woods, Sandra, Mogg, Robin, Zhang, Lei, Finnefrock, Adam C, Rabussay, Dietmar, Fons, Michael, Mallee, John, Mehrotra, Devan, Schödel, Florian, Musey, Luwy
Published in Molecular therapy (01.05.2009)
Published in Molecular therapy (01.05.2009)
Get full text
Journal Article